Disciplined Investors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Buy
+624
New +$231K 0.12% 128
2026
Q1
Sell
-726
Closed -$255K 142
2025
Q4
$255K Sell
726
-178
-20% -$60.2K 0.17% 108
2025
Q3
$292K Hold
904
0.21% 94
2025
Q2
$352K Sell
904
-1
-0.1% -$402 0.27% 77
2025
Q1
$394K Sell
905
-101
-10% -$40.5K 0.36% 65
2024
Q4
$399K Buy
+1,006
New +$421K 0.38% 61

Other funds holding ELV

Disciplined Investors's ELV Position: Q2 2026 in Review

Disciplined Investors opened a new position in Elevance Health (ELV) in Q2 2026: 624 shares worth $242K. The stake represents 0.12% of the portfolio and ranks #128 among its holdings. This is a return to the name: Disciplined Investors previously reported a position in ELV as recently as Q4 2025.

Disciplined Investors first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $399K in Q4 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Disciplined Investors held 624 shares of Elevance Health worth $242K as of Q2 2026.
  • Elevance Health was a new Disciplined Investors position in Q2 2026.
  • Elevance Health made up 0.12% of Disciplined Investors's portfolio in Q2 2026, its #128 holding.
  • Disciplined Investors first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Disciplined Investors's Elevance Health position peaked at $399K in Q4 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Disciplined Investors's 13F filing for Q2 2026, filed 11 Aug 2026.